Navigation Links
Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test
Date:11/17/2010

TAG CYP2D6 Kit is not indicated for stand-alone diagnostic purposes and is not intended to be used to predict drug response or non-response.  

For more information, call 512.219.8020, or visit www.luminexcorp.com.

About Luminex CorporationLuminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP can be obtained at www.luminexcorp.com.Luminex Investor Contact:  Matt Scalo, Senior Director of Investor Relations  512.219.8020  mscalo@luminexcorp.com Luminex Media Contacts:  Mimi L. Torrington, Director of Marketing Communications 512.219.8020  mtorrington@luminexcorp.com Brandon Brunson512.241.2234Brandon.Brunson@porternovelli.com
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Luminex Corporation to Present at Stephens Fall Investment Conference
2. Luminex Corporation Reports Third Quarter 2010 Results
3. Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2010
4. Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
5. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
6. Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
7. Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
8. Luminex Corporation to Present at UBS Global Life Sciences Conference
9. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
10. Luminex Announces Commercial Launch of New Cystic Fibrosis Test
11. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... 3, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... collaboration to discover and develop antisense therapies for ... builds on a broad existing relationship between the ... these therapeutic areas using novel RNA-targeted treatments. It ... its antisense technology to diseases of the kidney. ...
(Date:8/2/2015)... -- Mandatory takeover offer for the ... the "Company") is pleased to announce the signing of ... Marijan Han žeković to acquire his 63.3% holding (equivalent ... Croatian listed pharmaceutical business.   Dechra is ... €51.4 million for the entire share capital on a ...
(Date:8/2/2015)... 2015  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ... 3 clinical trial met its primary endpoint, showing ... cancer patients with carcinoid syndrome that is not ... Telotristat etiprate was discovered using Lexicon,s gene science, ... company,s first discovery to complete a pivotal Phase ...
Breaking Medicine Technology:AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6
... 16 Westside Medical Associates of Los Angeles ... announce the benefit of early positron emission tomography ... treatable phase. According to Dr. Norman Lepor , Professor of ... and Co-director of Imaging at WMI, "the research investigators at the ...
... American pharmaceutical manufacturer Alpharma Inc. has agreed to pay ... in connection with the marketing of the morphine-based drug, Kadian, ... between January 1, 2000 and December 29, ... to promote or prescribe Kadian, and made misrepresentations about the ...
Cached Medicine Technology:Early Identification of Alzheimer's Disease With PET Scan 2Early Identification of Alzheimer's Disease With PET Scan 3Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian 2Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian 3
(Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular ... IBAM NA’s cyclotron sites and research and development facilities. , “We are ... as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO ...
(Date:8/3/2015)... ... 2015 , ... Dignity Health named Dr. Norris A. Baldwin, Jr. the Facility ... opening in August. The new facility is licensed under Dignity Health Arizona ... “Dr. Baldwin is an excellent leader and will ensure our new freestanding emergency room ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... firm, announced today that Joe Williams has joined its growing California employee benefits ... HUB's differentiated service model to his clients. Mr. Williams will be joining the ...
(Date:8/3/2015)... Miami, Florida (PRWEB) , ... August 03, 2015 , ... ... neuropathy pain accompanied by tissue injury caused by diabetes after many years of suffering ... work many times, and he didn’t want to ask for extra time off or ...
(Date:8/3/2015)... ... 03, 2015 , ... Cambia Health Solutions has promoted Scott ... company’s Medicare and Federal Employee Programs (FEP) lines of business. , Government ... members. In this role, Scott is responsible for overseeing the growth, finance and ...
Breaking Medicine News(10 mins):Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2
... Heart Institute is the lead enroller in the world for ... repair for severe mitral valve regurgitation with conventional surgery. In ... first Evalve MitraClip in California, and was also first on ... procedure. Cedars-Sinai is believed to be the most experienced center ...
... debate continues on whether the nutrient should be recommended for ... patients with high blood levels of vitamin D boost their ... , Previous studies have indicated that high levels of vitamin ... 51 percent, although other studies dispute that claim. But until ...
... Senior,Living Inc. (NYSE: BKD ) announced today that ... 2008 Jefferies Healthcare,Conference in New York, New York on ... The presentation is being webcast live and can be ... at, http://www.brookdaleliving.com . A replay of the webcast will ...
... Adds $47 million in annual revenues and eight locations in New ... Connecticut, and ... AFAM ), a leading regional provider of home health nursing,services, ... stock of Patient Care, Inc. This acquisition, the Company,s,largest to date, ...
... Message to Fans, TALLAHASSEE, Fla., June 19 ... top-ranked Florida Marlins and Tampa Bay,Rays are leading a ... Free Florida, an initiative of the Florida Department of,Health, ... Floridians with,its messages of smoking and smokeless tobacco prevention ...
... 19 /PRNewswire-FirstCall/,-- Cord Blood America, Inc. (OTC ... cell preservation company ( http://www.cordblood-america.com ),focused ... stem cells to families,nationwide and internationally, today ... in enacting legislation requiring health care facilities ...
Cached Medicine News:Health News:Evalve MitraClip: Clinical trial of nonsurgical repair for severe mitral valve regurgitation 2Health News:Vitamin D May Promote Colon Cancer Survival 2Health News:Vitamin D May Promote Colon Cancer Survival 3Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 2Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 3Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 4Health News:Rivalry Aside, Marlins and Rays Team Up To Fight Tobacco 2Health News:Cord Blood America Says Pennsylvania Joins New York and California in Informing Parents of the Advantages of Umbilical Cord Blood Storage 2
... The WideBiter Punch series facilitates fast ... recreating a smooth, anatomically shaped meniscal rim. ... low profile to access even the tightest ... Arthrex California, Inc., 20 years of engineering ...
... The WideBiter Punch series facilitates fast and ... a smooth, anatomically shaped meniscal rim. The ... profile to access even the tightest joint ... California, Inc., 20 years of engineering experience ...
... The WideBiter Punch series facilitates fast and ... a smooth, anatomically shaped meniscal rim. The ... profile to access even the tightest joint ... California, Inc., 20 years of engineering experience ...
... design provides fingertip ratchet disengagement allowing smooth, ... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ...
Medicine Products: